| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| Bajaj Finserv Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
3.08 |
| Equity |
96.75 |
| Trep |
0.17 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
30.51% |
| Top 10 Holdings |
47.17% |
| Top 25 Holdings |
82.36% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
64.05 |
| Healthcare |
20.09 |
| Retail |
4.58 |
| Cash |
3.25 |
| Food Beverage & Tobacco |
2.1 |
| FMCG |
1.6 |
| Miscellaneous |
1.57 |
| Industrial Products |
1.15 |
| Agricultural & Farm Machinery |
0.66 |
| Technology |
0.52 |
| Chemicals |
0.43 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
5.74 |
| PE Ratio |
45.80 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| DIVI LABORATORIES LTD |
7.94 |
| Sun Pharmaceutical Industries Limited |
7.48 |
| Apollo Hospitals Enterprise Limited |
6.01 |
| Cipla Limited |
5.32 |
| Biocon Limited |
3.76 |
| Glenmark Pharmaceuticals Limited |
3.45 |
| Emcure Pharmaceuticals Limited |
3.39 |
| Dr Reddys Laboratories Limited |
3.37 |
| Syngene International Limited |
3.25 |
| Fortis Health Care Ltd |
3.20 |
| Piramal Pharma Limited |
3.15 |
| Dr Lal Path Labs Ltd |
3.09 |
| Net Receivables / (Payables) |
3.08 |
| Neuland Laboratories Limited |
3.00 |
| Aurobindo Pharma Limited |
2.89 |
| Pfizer Limited |
2.48 |
| Torrent Pharmaceuticals Limited |
2.42 |
| IPCA Laboratories Limited |
2.18 |
| Lupin Limited |
2.05 |
| Vijaya Diagnostic Centre Limited |
1.94 |
| Glaxosmithkline Pharma Ltd |
1.86 |
| Godrej Consumer Products Limited |
1.84 |
| SANOFI CONSUMER HEALTHCARE |
1.82 |
| Abbott India Limited |
1.75 |
| Zydus Wellness Limited |
1.64 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
